Repaglinide

CAS 135062-02-1 16 API suppliersSmall Molecule

Overview

Repaglinide is an oral medication used to manage Type 2 diabetes mellitus by stimulating the release of insulin from pancreatic beta cells. It is classified as a meglitinide and helps control blood sugar levels post-prandially.

API suppliers (17)

Suppliers of Repaglinide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India8China3Germany1France1Iceland1

Country recorded for 14 of 17 suppliers.

7 of 17 hold a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance

Therapeutic areas

DiabetesEndocrinology
Verified Supplier Partner

Do you supply Repaglinide? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.